Extracorporeal hepatic resection for advanced liver cancer

Keishi Sugimachi, Ken Shirabe, Akinobu Taketomi, Yuji Soejima, Hideaki Uchiyama, Mizuki Ninomiya, Hiroto Kayashima, Dai Kitagawa, Hidefumi Higashi, Yoshihiko Maehara

Research output: Contribution to journalArticle

Abstract

Hepatic resection is the most curative treatment for the patient with hepatocellular carcinoma (HCC) which occurs in the non-cirrhotic liver. It is not common, but extracorporeal hepatic resection (EHR) is sometimes considered as the treatment of otherwise unresectable tumors due to the location, size, and vascular invasion of the tumor. In the EHR, the liver is completely removed and perfused with the preservation solution. Bloodless transection of hepatic parenchyma is done, and reimplanted in the patient. Preoperative assessment of the vascular anatomy and liver volume, advanced surgical technique of hepatic resection and transplantation, and experienced postoperative care are essential to the accomplishment of EHR. In this issue, we give an outline of the indication, procedures, and the problems of EHR.

Original languageEnglish
Pages (from-to)399-401
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume37
Issue number3
Publication statusPublished - Mar 6 2010

Fingerprint

Liver Neoplasms
Liver
Blood Vessels
Postoperative Care
Liver Transplantation
Hepatocellular Carcinoma
Neoplasms
Anatomy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Sugimachi, K., Shirabe, K., Taketomi, A., Soejima, Y., Uchiyama, H., Ninomiya, M., ... Maehara, Y. (2010). Extracorporeal hepatic resection for advanced liver cancer. Japanese Journal of Cancer and Chemotherapy, 37(3), 399-401.

Extracorporeal hepatic resection for advanced liver cancer. / Sugimachi, Keishi; Shirabe, Ken; Taketomi, Akinobu; Soejima, Yuji; Uchiyama, Hideaki; Ninomiya, Mizuki; Kayashima, Hiroto; Kitagawa, Dai; Higashi, Hidefumi; Maehara, Yoshihiko.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 37, No. 3, 06.03.2010, p. 399-401.

Research output: Contribution to journalArticle

Sugimachi, K, Shirabe, K, Taketomi, A, Soejima, Y, Uchiyama, H, Ninomiya, M, Kayashima, H, Kitagawa, D, Higashi, H & Maehara, Y 2010, 'Extracorporeal hepatic resection for advanced liver cancer', Japanese Journal of Cancer and Chemotherapy, vol. 37, no. 3, pp. 399-401.
Sugimachi K, Shirabe K, Taketomi A, Soejima Y, Uchiyama H, Ninomiya M et al. Extracorporeal hepatic resection for advanced liver cancer. Japanese Journal of Cancer and Chemotherapy. 2010 Mar 6;37(3):399-401.
Sugimachi, Keishi ; Shirabe, Ken ; Taketomi, Akinobu ; Soejima, Yuji ; Uchiyama, Hideaki ; Ninomiya, Mizuki ; Kayashima, Hiroto ; Kitagawa, Dai ; Higashi, Hidefumi ; Maehara, Yoshihiko. / Extracorporeal hepatic resection for advanced liver cancer. In: Japanese Journal of Cancer and Chemotherapy. 2010 ; Vol. 37, No. 3. pp. 399-401.
@article{88dab3baff31479792bcc85a3bdb3e0c,
title = "Extracorporeal hepatic resection for advanced liver cancer",
abstract = "Hepatic resection is the most curative treatment for the patient with hepatocellular carcinoma (HCC) which occurs in the non-cirrhotic liver. It is not common, but extracorporeal hepatic resection (EHR) is sometimes considered as the treatment of otherwise unresectable tumors due to the location, size, and vascular invasion of the tumor. In the EHR, the liver is completely removed and perfused with the preservation solution. Bloodless transection of hepatic parenchyma is done, and reimplanted in the patient. Preoperative assessment of the vascular anatomy and liver volume, advanced surgical technique of hepatic resection and transplantation, and experienced postoperative care are essential to the accomplishment of EHR. In this issue, we give an outline of the indication, procedures, and the problems of EHR.",
author = "Keishi Sugimachi and Ken Shirabe and Akinobu Taketomi and Yuji Soejima and Hideaki Uchiyama and Mizuki Ninomiya and Hiroto Kayashima and Dai Kitagawa and Hidefumi Higashi and Yoshihiko Maehara",
year = "2010",
month = "3",
day = "6",
language = "English",
volume = "37",
pages = "399--401",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - Extracorporeal hepatic resection for advanced liver cancer

AU - Sugimachi, Keishi

AU - Shirabe, Ken

AU - Taketomi, Akinobu

AU - Soejima, Yuji

AU - Uchiyama, Hideaki

AU - Ninomiya, Mizuki

AU - Kayashima, Hiroto

AU - Kitagawa, Dai

AU - Higashi, Hidefumi

AU - Maehara, Yoshihiko

PY - 2010/3/6

Y1 - 2010/3/6

N2 - Hepatic resection is the most curative treatment for the patient with hepatocellular carcinoma (HCC) which occurs in the non-cirrhotic liver. It is not common, but extracorporeal hepatic resection (EHR) is sometimes considered as the treatment of otherwise unresectable tumors due to the location, size, and vascular invasion of the tumor. In the EHR, the liver is completely removed and perfused with the preservation solution. Bloodless transection of hepatic parenchyma is done, and reimplanted in the patient. Preoperative assessment of the vascular anatomy and liver volume, advanced surgical technique of hepatic resection and transplantation, and experienced postoperative care are essential to the accomplishment of EHR. In this issue, we give an outline of the indication, procedures, and the problems of EHR.

AB - Hepatic resection is the most curative treatment for the patient with hepatocellular carcinoma (HCC) which occurs in the non-cirrhotic liver. It is not common, but extracorporeal hepatic resection (EHR) is sometimes considered as the treatment of otherwise unresectable tumors due to the location, size, and vascular invasion of the tumor. In the EHR, the liver is completely removed and perfused with the preservation solution. Bloodless transection of hepatic parenchyma is done, and reimplanted in the patient. Preoperative assessment of the vascular anatomy and liver volume, advanced surgical technique of hepatic resection and transplantation, and experienced postoperative care are essential to the accomplishment of EHR. In this issue, we give an outline of the indication, procedures, and the problems of EHR.

UR - http://www.scopus.com/inward/record.url?scp=79960764909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960764909&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 399

EP - 401

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 3

ER -